Gut microbes play a crucial role in human health, and understanding the forces behind the growth of beneficial bacterial species in the gut may enable medical interventions that promote overall human health. A recent study by Yale researchers, published in the journal Science, has uncovered a new mechanism by which these bacteria colonize the gut.

The Yale team discovered that one of the most abundant beneficial species in the human gut, Bacteroides thetaiotaomicron, showed increased colonization potential when experiencing carbon limitation. Carbon is a primary building block for all cells, and the deprivation of nutrients, including carbon, elicits the production of colonization factors in beneficial gut bacteria.

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

The team found that the bacteria responded to carbon starvation by sequestering a portion of the molecules for an essential transcription factor within a membrane-less compartment. Sequestration of the transcription factor increased its activity, modifying the expression of hundreds of bacterial genes, including several that promote gut colonization and control central metabolic pathways in the bacterium.

The researchers established that "good" bacteria use sequestration of molecules into membrane-less compartments to colonize the mammalian gut. The findings could help develop new probiotic therapies for gut health.

The study's lead author, Aimilia Krypotou, a postdoctoral fellow in Eduardo Groisman's lab, says, "Most studies just look at the abundance of bacterium. If we don't understand what's happening at the molecular level, we don't know if it would help." The team hypothesized that the extra region in the transcription factor might confer a new biophysical property to the protein required for the bacteria to survive in the gut, and successfully performed a series of experiments to test the hypothesis.

These findings are significant, as ongoing clinical trials aim to manipulate the gut microbiota to tackle various diseases. However, there is limited knowledge about the factors and mechanisms that make beneficial bacteria colonize successfully within the gut. By further understanding these processes, medical interventions could be developed to promote gut and overall human health.